C-reactive protein, fibrinogen, and cardiovascular disease prediction (Q37021409)

17 August 2017

C-reactive protein, fibrinogen, and cardiovascular disease prediction (English)

1 reference

17 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

author

Elizabeth Barrett-Connor

17

Elizabeth Barrett-Connor

0 references

Emelia J. Benjamin

18

Emelia J Benjamin

0 references

Deborah A. Lawlor

50

Debbie A Lawlor

0 references

Børge G. Nordestgaard

53

Sylvia Wassertheil-Smoller

Børge G Nordestgaard

0 references

69

Sylvia Wassertheil-Smoller

1 reference

17 August 2017

Rachel Dankner

28

0 references

Adam S. Butterworth

Adam S Butterworth

12

0 references

Emanuele Di Angelantonio

Emanuele Di Angelantonio

3

0 references

Mary Cushman

Mary Cushman

25

0 references

Gunnar Engström

Gunnar Engström

32

0 references

Peter H. Whincup

Peter H Whincup

72

0 references

Timo Strandberg

Timo E Strandberg

66

0 references

Vilmundur Gudnason

Vilmundur Gudnason

80

0 references

Philippe Amouyel

Philippe Amouyel

13

0 references

Torben Jørgensen

Torben Jørgensen

43

0 references

Hermann Brenner

Hermann Brenner

20

0 references

Veikko Salomaa

59

Veikko Salomaa

1 reference

17 August 2017

77

Kay-Tee Khaw

1 reference

17 August 2017

76

Nicholas J Wareham

1 reference

17 August 2017

41

Erik Ingelsson

1 reference

17 August 2017

78

Naveed Sattar

1 reference

Emerging Risk Factors Collaboration

17 August 2017

1

Emerging Risk Factors Collaboration

1 reference

17 August 2017

71

Rudi G Westendorp

1 reference

17 August 2017

33

Aaron R Folsom

1 reference

17 August 2017

39

Albert Hofman

1 reference

17 August 2017

47

Wolfgang Koenig

1 reference

17 August 2017

58

Annika Rosengren

1 reference

17 August 2017

31

Jacqueline M Dekker

1 reference

Coenraad Dirk Adriaan Stehouwer

17 August 2017

65

Coen D A Stehouwer

1 reference

17 August 2017

56

Bruce M Psaty

1 reference

17 August 2017

40

Barbara V Howard

1 reference

17 August 2017

49

Lewis H Kuller

1 reference

17 August 2017

81

Paul M Ridker

1 reference

Demosthenes B. Panagiotakos

17 August 2017

55

Demosthenes B Panagiotakos

1 reference

17 August 2017

29

George Davey-Smith

1 reference

17 August 2017

84

John Danesh

1 reference

17 August 2017

30

Dorly Deeg

1 reference

17 August 2017

7

Pei Gao

1 reference

17 August 2017

2

Stephen Kaptoge

1 reference

17 August 2017

38

Richard F Gillum

1 reference

17 August 2017

61

Jukka T Salonen

1 reference

17 August 2017

51

Tom W Meade

1 reference

17 August 2017

21

Eric Brunner

1 reference

17 August 2017

4

Lisa Pennells

1 reference

17 August 2017

60

Jussi Kauhanen

1 reference

17 August 2017

19

Cecilia Björkelund

1 reference

17 August 2017

73

Lars Wilhelmsen

1 reference

17 August 2017

52

Aulikki Nissinen

1 reference

17 August 2017

37

Simona Giampaoli

1 reference

17 August 2017

35

John Gallacher

1 reference

17 August 2017

14

Gerd Assmann

1 reference

17 August 2017

26

Gilles R Dagenais

1 reference

17 August 2017

11

Muriel Caslake

1 reference

17 August 2017

10

Nadeem Sarwar

1 reference

17 August 2017

34

F Gerry R Fowkes

1 reference

17 August 2017

62

Jonathan A Shaffer

1 reference

17 August 2017

70

Patrik Wennberg

1 reference

17 August 2017

75

Gordon D O Lowe

1 reference

17 August 2017

45

Akihiko Kitamura

1 reference

17 August 2017

46

Yutaka Kiyohara

1 reference

17 August 2017

57

Beatriz Rodriguez

1 reference

17 August 2017

48

Daan Kromhout

1 reference

17 August 2017

Ralph B. D'Agostino Sr.

27

Ralph B D'Agostino

1 reference

17 August 2017

Angela M Wood

5

1 reference

17 August 2017

Ian R White

6

1 reference

17 August 2017

Matthew Walker

8

1 reference

17 August 2017

Alexander Thompson

9

1 reference

17 August 2017

Stephan J L Bakker

15

1 reference

17 August 2017

Elizabeth L M Barr

16

1 reference

17 August 2017

Robert Clarke

22

1 reference

17 August 2017

Jackie A Cooper

23

1 reference

17 August 2017

Peter Cremer

24

1 reference

17 August 2017

J Michael Gaziano

36

1 reference

17 August 2017

Hiroyasu Iso

42

1 reference

17 August 2017

Stefan Kiechl

44

1 reference

17 August 2017

Altan Onat

54

1 reference

17 August 2017

Steven Shea

63

1 reference

17 August 2017

Ian Ford

64

1 reference

17 August 2017

Robert W Tipping

67

1 reference

17 August 2017

Alberto Tosetto

68

1 reference

17 August 2017

Mark Woodward

74

1 reference

17 August 2017

Chris J Packard

79

1 reference

17 August 2017

Mark B Pepys

82

1 reference

17 August 2017

Simon G Thompson

83

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2012

1 reference

The New England Journal of Medicine

17 August 2017

1 reference

17 August 2017

367

1 reference

17 August 2017

1310-1320

1 reference

17 August 2017

14

1 reference

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20,536 patients in the Heart Protection Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Risk assessment and lipid modification for primary and secondary prevention of cardiovascular disease: summary of NICE guidance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Quantifying heterogeneity in a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Prediction of Coronary Heart Disease Using Risk Factor Categories

29 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

29 September 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Measures to assess the prognostic ability of the stratified Cox proportional hazards model

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3714101

Simple indices of inflammation as predictors of death from cancer or cardiovascular disease in a prospective cohort after two decades of follow-up

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23034020

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Probability of stroke: a risk profile from the Framingham Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23034020

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA1107477

1 reference

17 August 2017

1 reference

17 August 2017

1 reference